IL6 and metabolic syndrome: This reduces the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), thereby mitigating chronic inflammation, a central feature of metabolic syndrome [148].